Log in

Relevant bibliographies by topics / Cancer nanotechnology / Journal articles

To see the other types of publications on this topic, follow the link: Cancer nanotechnology.

Journal articles on the topic 'Cancer nanotechnology'

Author: Grafiati

Published: 4 June 2021

Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Cancer nanotechnology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Jagdale, SwatiC, TejasP Shah, BhanudasS Kuchekar, AniruddhaR Chabukswar, and DhirajT Baviskar. "Cancer nanotechnology." Asian Journal of Pharmaceutics 3, no. 1 (2009): 4. http://dx.doi.org/10.4103/0973-8398.49166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Grodzinski, Piotr, and Vladimir Torchilin. "Cancer nanotechnology." Advanced Drug Delivery Reviews 66 (February 2014): 1. http://dx.doi.org/10.1016/j.addr.2013.09.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Misra, Ranjita, Sarbari Acharya, and Sanjeeb K. Sahoo. "Cancer nanotechnology: application of nanotechnology in cancer therapy." Drug Discovery Today 15, no. 19-20 (October 2010): 842–50. http://dx.doi.org/10.1016/j.drudis.2010.08.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bradley, David. "Nanotechnology fights cancer." Materials Today 13, no. 6 (June 2010): 10. http://dx.doi.org/10.1016/s1369-7021(10)70097-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Parida, Sushree, and Tushar Kanti Das. "Nanotechnology and Cancer." Apollo Medicine 5, no. 3 (September 2008): 250–52. http://dx.doi.org/10.1016/s0976-0016(11)60497-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Heath, James R., and Mark E. Davis. "Nanotechnology and Cancer." Annual Review of Medicine 59, no. 1 (February 2008): 251–65. http://dx.doi.org/10.1146/annurev.med.59.061506.185523.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bosetti, Rita, and Lode Vereeck. "On Cancer Nanotechnology." Key Engineering Materials 441 (June 2010): 307–32. http://dx.doi.org/10.4028/www.scientific.net/kem.441.307.

Full text

Abstract:

Although governments invest billions of dollars in cancer research, cancer remains one of the major causes of death worldwide (Liu et al., 2007). During the last decades, outstanding results have been attained in fundamental cancer biology but, unfortunately, they have not been translated in even distantly comparable progressions in the clinic. The main reason for this gap being the inability to administer therapeutic agents so that they can reach target cells without or with minimal side-effects (Ferrari, 2005). Today, scientists are faced with the recognition that very few molecules reach the desired locations and thus fail to selectively reach the target cells. Consequently, patients experience a very poor quality of life (Ferrari, 2004; Ferrari, 2005; Chan, 2006).

APA, Harvard, Vancouver, ISO, and other styles

8

Darmawikarta, Denise, and Alexander Pazionis. "Nanotechnology in cancer therapeutics." University of Western Ontario Medical Journal 82, no. 2 (July 30, 2014): 20–21. http://dx.doi.org/10.5206/uwomj.v82i2.4590.

Full text

Abstract:

The field of cancer therapeutics is rapidly evolving. Of particular interest is the potential for nanotechnology to overcome one of chemotherapy’s biggest barriers: targeted drug delivery. Owing to the sheer small size of nanoparticles, the opportunity arises for chemotherapy to be administered much more accurately to cancer cells while sparing healthy adjacent tissues. In this article, we review the various tools in nanotechnology that have emerged as candidate delivery systems for chemotherapeutic agents. We discuss the ways in which nanotechnology has been demonstrated to eradicate cancer cells and comment on both successes and current limitations.

APA, Harvard, Vancouver, ISO, and other styles

9

Acharya, Aditi. "Nanotechnology for Cancer Treatment." INROADS- An International Journal of Jaipur National University 5, no. 1s (2016): 30. http://dx.doi.org/10.5958/2277-4912.2016.00006.0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Aslan, Burcu, Bulent Ozpolat, Anil K. Sood, and Gabriel Lopez-Berestein. "Nanotechnology in cancer therapy." Journal of Drug Targeting 21, no. 10 (September 30, 2013): 904–13. http://dx.doi.org/10.3109/1061186x.2013.837469.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Liang, Xing-Jie. "Nanotechnology and cancer nanomedicine." Biotechnology Advances 32, no. 4 (July 2014): 665. http://dx.doi.org/10.1016/j.biotechadv.2014.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pope-Harman, Amy, Mark Ming-Cheng Cheng, Fredika Robertson, Jason Sakamoto, and Mauro Ferrari. "Biomedical Nanotechnology for Cancer." Medical Clinics of North America 91, no. 5 (September 2007): 899–927. http://dx.doi.org/10.1016/j.mcna.2007.05.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ferrari, Mauro, Anna D. Barker, and Gregory J. Downing. "A Cancer Nanotechnology Strategy." NanoBiotechnology 1, no. 2 (2005): 129–32. http://dx.doi.org/10.1385/nbt:1:2:129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Barker, A. D. "Nanotechnology and cancer prevention." European Journal of Cancer Supplements 4, no. 1 (January 2006): 9. http://dx.doi.org/10.1016/s1359-6349(06)80480-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Nie, Shuming, Yun Xing, Gloria J. Kim, and Jonathan W. Simons. "Nanotechnology Applications in Cancer." Annual Review of Biomedical Engineering 9, no. 1 (August 15, 2007): 257–88. http://dx.doi.org/10.1146/annurev.bioeng.9.060906.152025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Errico, Alessia. "Nanotechnology targets cancer cells." Nature Reviews Clinical Oncology 10, no. 12 (October 15, 2013): 667. http://dx.doi.org/10.1038/nrclinonc.2013.186.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Grossman, Jennifer H., and Scott E. McNeil. "Nanotechnology in Cancer Medicine." Physics Today 65, no. 8 (August 2012): 38–42. http://dx.doi.org/10.1063/pt.3.1678.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Mali, Shrikant Balasaheb. "Update in cancer nanotechnology." Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 27, no. 6 (November 2015): 852–53. http://dx.doi.org/10.1016/j.ajoms.2015.05.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Moumaris, Mohamed, Jean-Michel Bretagne, and Nisen Abuaf. "Nanomedical Devices and Cancer Theranostics." Open Nanomedicine and Nanotechnology Journal 6, no. 1 (April 21, 2020): 1–11. http://dx.doi.org/10.2174/2666150002006010001.

Full text

Abstract:

The current therapies against cancer showed limited success. Nanotechnology is a promising strategy for cancer tracking, diagnosis, and therapy. The hybrid nanotechnology assembled several materials in a multimodal system to develop multifunctional approaches to cancer treatment. The quantum dot and polymer are some of these hybrid nanoparticle platforms. The quantum dot hybrid system possesses photonic and magnetic properties, allowing photothermal therapy and live multimodal imaging of cancer. These quantum dots were used to convey medicines to cancer cells. Hybrid polymer nanoparticles were utilized for the systemic delivery of small interfering RNA to malignant tumors and metastasis. They allowed non-invasive imaging to track in real-time the biodistribution of small interfering RNA in the whole body. They offer an opportunity to treat cancers by specifically silencing target genes. This review highlights the major nanotechnology approaches to effectively treat cancer and metastasis.

APA, Harvard, Vancouver, ISO, and other styles

20

Bockamp, Ernesto, Sebastian Rosigkeit, Dominik Siegl, and Detlef Schuppan. "Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology." Cells 9, no. 9 (September 15, 2020): 2102. http://dx.doi.org/10.3390/cells9092102.

Full text

Abstract:

Cancer immunotherapy utilizes the immune system to fight cancer and has already moved from the laboratory to clinical application. However, and despite excellent therapeutic outcomes in some hematological and solid cancers, the regular clinical use of cancer immunotherapies reveals major limitations. These include the lack of effective immune therapy options for some cancer types, unresponsiveness to treatment by many patients, evolving therapy resistance, the inaccessible and immunosuppressive nature of the tumor microenvironment (TME), and the risk of potentially life-threatening immune toxicities. Given the potential of nanotechnology to deliver, enhance, and fine-tune cancer immunotherapeutic agents, the combination of cancer immunotherapy with nanotechnology can overcome some of these limitations. In this review, we summarize innovative reports and novel strategies that successfully combine nanotechnology and cancer immunotherapy. We also provide insight into how nanoparticular combination therapies can be used to improve therapy responsiveness, to reduce unwanted toxicity, and to overcome adverse effects of the TME.

APA, Harvard, Vancouver, ISO, and other styles

21

Singh, Keshav K. "Nanotechnology in Cancer Detection and Treatment." Technology in Cancer Research & Treatment 4, no. 6 (December 2005): 583. http://dx.doi.org/10.1177/153303460500400601.

Full text

Abstract:

Nanotechnology is an emerging interdisciplinary field dedicated to the manipulations of atoms and molecules that lead to the construction of structures in the nanometer scale size range that retain unique properties (1). In the past decade, the field of nanotechnology has grown into a diverse interdisciplinary mix of engineering, computer science, biology, and medicine. Through nanotechnology, we are now able to study unique biology, chemistry, and physics at nanoscale levels. The field of nanotechnology shows promise in cancer. This special issue on nanotechnology in cancer contains articles that focus on the application of nanotechnology in advancing cancer detection, diagnosis, and treatment. The aim of the issue is to present to the cancer community a review of the current status of cancer nanotechnology, which is rapidly advancing. Recently, many nanotechnology tools have become available which can make it possible for clinicians to detect tumors at an early stage. The nanostructures can potentially enter the single tumor cell, which can help improve the current detection limit by imaging techniques described in this issue. The goal, for example, in the case of breast cancer is to accurately detect less than 100 tumor cells in contrast to mammography, which requires more than 1,000,000 cells for clinical diagnosis. Targeting and local tumor delivery is the key challenges in both diagnosis and treatment of cancer. Nanotechnology can help diagnose cancer using dendrimers and kill tumor cells without harming normal healthy cells by tumor selective delivery of genes using nanovectors. These and other technologies currently are in various stages of discovery and development. The papers presented in this issue give an overall view of how the field is advancing.

APA, Harvard, Vancouver, ISO, and other styles

22

Zamboni, William C., Vladimir Torchilin, Anil K. Patri, Jeff Hrkach, Stephen Stern, Robert Lee, Andre Nel, Nicholas J. Panaro, and Piotr Grodzinski. "Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance." Clinical Cancer Research 18, no. 12 (June 5, 2012): 3229–41. http://dx.doi.org/10.1158/1078-0432.ccr-11-2938.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Wang, May D., Dong M. Shin, Jonathan W. Simons, and Shuming Nie. "Nanotechnology for targeted cancer therapy." Expert Review of Anticancer Therapy 7, no. 6 (June 2007): 833–37. http://dx.doi.org/10.1586/14737140.7.6.833.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Grodzinski, Piotr. "Themed issue on Cancer Nanotechnology." Integrative Biology 5, no. 1 (November 26, 2012): 17–18. http://dx.doi.org/10.1039/c2ib90050e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Choi, Young-Eun, Ju-Won Kwak, and Joon Won Park. "Nanotechnology for Early Cancer Detection." Sensors 10, no. 1 (January 6, 2010): 428–55. http://dx.doi.org/10.3390/s100100428.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Kumar, Vinit, Stefano Palazzolo, Samer Bayda, Giuseppe Corona, Giuseppe Toffoli, and Flavio Rizzolio. "DNA Nanotechnology for Cancer Therapeutics." Theranostics 6, no. 5 (2016): 710–25. http://dx.doi.org/10.7150/thno.14203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lin, Yao-Xin, Yi Wang, Sara Blake, Mian Yu, Lin Mei, Hao Wang, and Jinjun Shi. "RNA Nanotechnology-Mediated Cancer Immunotherapy." Theranostics 10, no. 1 (2020): 281–99. http://dx.doi.org/10.7150/thno.35568.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Yue, Xiuli, and Zhifei Dai. "Liposomal Nanotechnology for Cancer Theranostics." Current Medicinal Chemistry 25, no. 12 (April 19, 2018): 1397–408. http://dx.doi.org/10.2174/0929867324666170306105350.

Full text

Abstract:

Liposomes are a type of biomimetic nanoparticles generated from self-assembling concentric lipid bilayer enclosing an aqueous core domain. They have been attractive nanocarriers for the delivery of many drugs (e.g. radiopharmaceuticals, chemotherapeutic agents, porphyrin) and diagnostic agents (e.g. fluorescent dyes, quantum dots, Gadolinium complex and Fe3O4) by encapsulating (or adsorbing) hydrophilic one inside the liposomal aqueous core domain (or on the bilayer membrane surface), and by entrapping hydrophobic one within the liposomal bilayer. Additionally, the liposome surface can be easily conjugated with targeting molecules. Liposomes may accumulate in cancerous tissues not only passively via enhanced permeability and retention (EPR) effect, but also actively by targeting cancer cell or angiogenic marker specifically. The multimodality imaging functionalization of liposomal therapeutic agents makes them highly attractive for individualized monitoring of the in vivo cancer targeting and pharmacokinetics of liposomes loading therapeutic drugs, and predicting therapeutic efficacy in combination with the helpful information from each imaging technique. The present review article will highlight some main advances of cancer theranostic liposomes with a view to activate further research in the nanomedicine community.

APA, Harvard, Vancouver, ISO, and other styles

29

Chan, Warren C. W., Ali Khademhosseini, Wolfgang Parak, and Paul S. Weiss. "Cancer: Nanoscience and Nanotechnology Approaches." ACS Nano 11, no. 5 (May 23, 2017): 4375–76. http://dx.doi.org/10.1021/acsnano.7b03308.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kobayashi, Hanako, and P. Charles Lin. "Nanotechnology for antiangiogenic cancer therapy." Nanomedicine 1, no. 1 (June 2006): 17–22. http://dx.doi.org/10.2217/17435889.1.1.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Sengupta, Poulomi, Sudipta Basu, and Shiladitya Sengupta. "Cancer, Signal Transduction and Nanotechnology." Current Drug Delivery 8, no. 3 (May 1, 2011): 254–60. http://dx.doi.org/10.2174/156720111795256147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Grodzinski, Piotr, Moritz Kircher, Michael Goldberg, and Alberto Gabizon. "Integrating Nanotechnology into Cancer Care." ACS Nano 13, no. 7 (June 26, 2019): 7370–76. http://dx.doi.org/10.1021/acsnano.9b04266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Goldberg, Michael S. "Improving cancer immunotherapy through nanotechnology." Nature Reviews Cancer 19, no. 10 (September 6, 2019): 587–602. http://dx.doi.org/10.1038/s41568-019-0186-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Schroeder, Avi, Daniel A. Heller, Monte M. Winslow, James E. Dahlman, George W. Pratt, Robert Langer, Tyler Jacks, and Daniel G. Anderson. "Treating metastatic cancer with nanotechnology." Nature Reviews Cancer 12, no. 1 (December 23, 2011): 39–50. http://dx.doi.org/10.1038/nrc3180.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sengupta, S., and R. Sasisekharan. "Exploiting nanotechnology to target cancer." British Journal of Cancer 96, no. 9 (April 3, 2007): 1315–19. http://dx.doi.org/10.1038/sj.bjc.6603707.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lou, Jenny, Li Zhang, and Gang Zheng. "Advancing Cancer Immunotherapies with Nanotechnology." Advanced Therapeutics 2, no. 4 (January 30, 2019): 1800128. http://dx.doi.org/10.1002/adtp.201800128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Cheng, Jianjun, and Suzie H. Pun. "Polymeric biomaterials for cancer nanotechnology." Biomaterials Science 3, no. 7 (2015): 891–93. http://dx.doi.org/10.1039/c5bm90025e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Banerjee, Hirendra N., and Mukesh Verma. "Application of Nanotechnology in Cancer." Technology in Cancer Research & Treatment 7, no. 2 (April 2008): 149–54. http://dx.doi.org/10.1177/153303460800700208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Nagahara, Larry A., Jerry S. H. Lee, Linda K. Molnar, Nicholas J. Panaro, Dorothy Farrell, Krzysztof Ptak, Joseph Alper, and Piotr Grodzinski. "Strategic Workshops on Cancer Nanotechnology." Cancer Research 70, no. 11 (May 11, 2010): 4265–68. http://dx.doi.org/10.1158/0008-5472.can-09-3716.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Ferrari, Mauro. "Cancer nanotechnology: opportunities and challenges." Nature Reviews Cancer 5, no. 3 (March 1, 2005): 161–71. http://dx.doi.org/10.1038/nrc1566.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Toy, Randall, Lisa Bauer, Christopher Hoimes, Ketan B. Ghaghada, and Efstathios Karathanasis. "Targeted nanotechnology for cancer imaging." Advanced Drug Delivery Reviews 76 (September 2014): 79–97. http://dx.doi.org/10.1016/j.addr.2014.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tanaka, Takemi, Paolo Decuzzi, Massimo Cristofanilli, Jason H. Sakamoto, Ennio Tasciotti, Fredika M. Robertson, and Mauro Ferrari. "Nanotechnology for breast cancer therapy." Biomedical Microdevices 11, no. 1 (July 29, 2008): 49–63. http://dx.doi.org/10.1007/s10544-008-9209-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Chauhan, Deepak S., Anupam Dhasmana, Partha Laskar, Rajendra Prasad, Nishant K. Jain, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan, and Murali M. Yallapu. "Nanotechnology synergized immunoengineering for cancer." European Journal of Pharmaceutics and Biopharmaceutics 163 (June 2021): 72–101. http://dx.doi.org/10.1016/j.ejpb.2021.03.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Badrealam, Khan Farheen, and Mohammad Owais. "Nano-Sized Drug Delivery Systems: Development and Implication in Treatment of Hepatocellular Carcinoma." Digestive Diseases 33, no. 5 (2015): 675–82. http://dx.doi.org/10.1159/000438497.

Full text

Abstract:

Liver cancer results in enormous human toll worldwide. Over the years, various chemotherapeutic entities have been employed for treatment of advanced HCC; however, as of yet none embody attributes to improve overall survival. Following rapid advancement in nanotechnology, it is envisage that nanoscale systems may emerge as intriguing platforms to improve chemotherapeutic strategies against various cancers including liver cancer; with better insight in the understanding of pathophysiology of liver cancer and material science, the field of nanotechnology may bring newer hope to liver cancer treatment. Reckoning with these, we detailed the arsenal of nanoformulations that are in various stages of clinical development/ preclinical settings for the treatment of liver cancer together with providing a glimpse of the attributes of nanotechnology in revolutionizing the status of chemotherapeutic modalities.

APA, Harvard, Vancouver, ISO, and other styles

45

Chaturvedi, Vivek K., Anshuman Singh, Vinay K. Singh, and Mohan P. Singh. "Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy." Current Drug Metabolism 20, no. 6 (July 17, 2019): 416–29. http://dx.doi.org/10.2174/1389200219666180918111528.

Full text

Abstract:

Background:Nanotechnology is gaining significant attention worldwide for cancer treatment. Nanobiotechnology encourages the combination of diagnostics with therapeutics, which is a vital component of a customized way to deal with the malignancy. Nanoparticles are being used as Nanomedicine which participates in diagnosis and treatment of various diseases including cancer. The unique characteristic of Nanomedicine i.e. their high surface to volume ratio enables them to tie, absorb, and convey small biomolecule like DNA, RNA, drugs, proteins, and other molecules to targeted site and thus enhances the efficacy of therapeutic agents.Objective:The objective of the present article is to provide an insight of several aspect of nanotechnology in cancer therapeutics such as various nanomaterials as drug vehicle, drug release strategies and role of nanotechnology in cancer therapy.Methods:We performed an extensive search on bibliographic database for research article on nanotechnology and cancer therapeutics and further compiled the necessary information from various articles into the present article.Results:Cancer nanotechnology confers a unique technology against cancer through early diagnosis, prevention, personalized therapy by utilizing nanoparticles and quantum dots.Nano-biotechnology plays an important role in the discovery of cancer biomarkers. Quantum dots, gold nanoparticles, magnetic nanoparticles, carbon nanotubes, gold nanowires etc. have been developed as a carrier of biomolecules that can detect cancer biomarkers. Nanoparticle assisted cancer detection and monitoring involves biomolecules like proteins, antibody fragments, DNA fragments, and RNA fragments as the base of cancer biomarkers.Conclusion:This review highlights various approaches of cancer nanotechnology in the advancement of cancer therapy.

APA, Harvard, Vancouver, ISO, and other styles

46

Sharma, Hemant K., and Manish Kumar. "RECENT INSIGHTS ON PROSPECTS OF CANCER NANOTECHNOLOGY." Asian Journal of Pharmaceutical Research and Development 6, no. 5 (October 18, 2018): 46–50. http://dx.doi.org/10.22270/ajprd.v6i5.413.

Full text

Abstract:

Cancer is an extremely multifaceted illness to appreciate, since it entails manifold cellular physiological system. The mainly general cancer treatment is limited to chemotherapy, radiation and surgery. Furthermore, the untimely credit and action of cancer relics a technological block. There is an urgent require to expand novel and originaltechnology thatcould help to define tumor margins, recognize residual tumor cells and micro metastases, and decide whether a tumor has been totally removed or not. Nanotechnology has witnessed significant progress in the past few decades, and its effect is widespread nowadays in every field. Nanoparticles can be modified in numerous ways to prolong circulation, enhance drug localization, increase drug efficacy, and potentially decrease chances of multidrug resistance by the use of nanotechnology. Recently, research in the field of cancer nanotechnology has made remarkable advances. In present study review summarizes the application of various nanotechnology-based approaches towards the diagnostics and therapeutics of cancer. Key-Words:Cancer Nanotechnology, Liposomes, Targeted Delivery, Diagnosis, Nano-medicines.

APA, Harvard, Vancouver, ISO, and other styles

47

Millagaha Gedara, Nuwan Indika, Xuan Xu, Robert DeLong, Santosh Aryal, and Majid Jaberi-Douraki. "Global Trends in Cancer Nanotechnology: A Qualitative Scientific Mapping Using Content-Based and Bibliometric Features for Machine Learning Text Classification." Cancers 13, no. 17 (September 1, 2021): 4417. http://dx.doi.org/10.3390/cancers13174417.

Full text

Abstract:

This study presents a new way to investigate comprehensive trends in cancer nanotechnology research in different countries, institutions, and journals providing critical insights to prevention, diagnosis, and therapy. This paper applied the qualitative method of bibliometric analysis on cancer nanotechnology using the PubMed database during the years 2000–2021. Inspired by hybrid medical models and content-based and bibliometric features for machine learning models, our results show cancer nanotechnology studies have expanded exponentially since 2010. The highest production of articles in cancer nanotechnology is mainly from US institutions, with several countries, notably the USA, China, the UK, India, and Iran as concentrated focal points as centers of cancer nanotechnology research, especially in the last five years. The analysis shows the greatest overlap between nanotechnology and DNA, RNA, iron oxide or mesoporous silica, breast cancer, and cancer diagnosis and cancer treatment. Moreover, more than 50% of the information related to the keywords, authors, institutions, journals, and countries are considerably investigated in the form of publications from the top 100 journals. This study has the potential to provide past and current lines of research that can unmask comprehensive trends in cancer nanotechnology, key research topics, or the most productive countries and authors in the field.

APA, Harvard, Vancouver, ISO, and other styles

48

Jain, K. K. "Nanotechnology-based Drug Delivery for Cancer." Technology in Cancer Research & Treatment 4, no. 4 (August 2005): 407–16. http://dx.doi.org/10.1177/153303460500400408.

Full text

Abstract:

Nanobiotechnologies have been applied to improve drug delivery and to overcome some of the problems of drug delivery in cancer. These can be classified into many categories that include use of various nanoparticles, nanoencapsulation, targeted delivery to tumors of various organs, and combination with other methods of treatment of cancer such as radiotherapy. Nanoparticles are also used for gene therapy for cancer. Some of the technologies enable combination of diagnostics with therapeutics which will be important for the personalized management of cancer. Some of the limitations of these technologies and prospects for future development are discussed.

APA, Harvard, Vancouver, ISO, and other styles

49

Salama, Lavinia, Elizabeth R. Pastor, Tyler Stone, and Shaker A. Mousa. "Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management." Biomedicines 8, no. 9 (September 12, 2020): 347. http://dx.doi.org/10.3390/biomedicines8090347.

Full text

Abstract:

Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technology has achieved considerable progress in the oncology field in recent years. Most chemotherapeutic agents are not specific to the cancer cells they are intended to treat, and they can harm healthy cells, leading to numerous adverse effects. Due to this non-specific targeting, it is not feasible to administer high doses that may harm healthy cells. Moreover, low doses can cause cancer cells to acquire resistance, thus making them hard to kill. A solution that could potentially enhance drug targeting and delivery lies in understanding the complexity of nanotechnology. Engineering pharmaceutical and natural products into nano-products can enhance the diagnosis and treatment of cancer. Novel nano-formulations such as liposomes, polymeric micelles, dendrimers, quantum dots, nano-suspensions, and gold nanoparticles have been shown to enhance the delivery of drugs. Improved delivery of chemotherapeutic agents targets cancer cells rather than healthy cells, thereby preventing undesirable side effects and decreasing chemotherapeutic drug resistance. Nanotechnology has also revolutionized cancer diagnosis by using nanotechnology-based imaging contrast agents that can specifically target and therefore enhance tumor detection. In addition to the delivery of drugs, nanotechnology can be used to deliver nutraceuticals like phytochemicals that have multiple properties, such as antioxidant activity, that protect cells from oxidative damage and reduce the risk of cancer. There have been multiple advancements and implications for the use of nanotechnology to enhance the delivery of both pharmaceutical and nutraceutical products in cancer prevention, diagnosis, and treatment.

APA, Harvard, Vancouver, ISO, and other styles

50

Baptista, Pedro. "Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy." Current Cancer Therapy Reviews 5, no. 2 (May 1, 2009): 80–88. http://dx.doi.org/10.2174/157339409788166733.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!